BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21734347)

  • 21. Alzheimer's disease, cholesterol, and statins: the junctions of important metabolic pathways.
    Silva T; Teixeira J; Remião F; Borges F
    Angew Chem Int Ed Engl; 2013 Jan; 52(4):1110-21. PubMed ID: 23280829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of the C-terminal proteolytic cleavage of AβPP by statins.
    Descamps O; Zhang Q; John V; Bredesen DE
    J Alzheimers Dis; 2011; 25(1):51-7. PubMed ID: 21422530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pleiotropic effects of statins in atherosclerosis: role on endothelial function, inflammation and immunomodulation.
    Arnaud C; Mach F
    Arch Mal Coeur Vaiss; 2005 Jun; 98(6):661-6. PubMed ID: 16007821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel reciprocal and biphasic relationship between membrane cholesterol and beta-secretase activity in SH-SY5Y cells and in human platelets.
    Liu WW; Todd S; Coulson DT; Irvine GB; Passmore AP; McGuinness B; McConville M; Craig D; Johnston JA
    J Neurochem; 2009 Jan; 108(2):341-9. PubMed ID: 19094065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease.
    Höglund K; Blennow K
    CNS Drugs; 2007; 21(6):449-62. PubMed ID: 17521225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholesterol in Alzheimer's disease and other amyloidogenic disorders.
    Harris JR; Milton NG
    Subcell Biochem; 2010; 51():47-75. PubMed ID: 20213540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statins: multiple neuroprotective mechanisms in neurodegenerative diseases.
    Wang Q; Yan J; Chen X; Li J; Yang Y; Weng J; Deng C; Yenari MA
    Exp Neurol; 2011 Jul; 230(1):27-34. PubMed ID: 20406638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pleiotropic effects of statins and related pharmacological experimental approaches.
    Alegret M; Silvestre JS
    Timely Top Med Cardiovasc Dis; 2007 Apr; 11():E10. PubMed ID: 17473899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statins in unconventional secretion of insulin-degrading enzyme and degradation of the amyloid-β peptide.
    Glebov K; Walter J
    Neurodegener Dis; 2012; 10(1-4):309-12. PubMed ID: 22205103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
    Danesh FR; Kanwar YS
    FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statins: drugs for Alzheimer's disease?
    Eckert GP; Wood WG; Müller WE
    J Neural Transm (Vienna); 2005 Aug; 112(8):1057-71. PubMed ID: 15682268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient four-drug cocktail therapy targeting amyloid-β peptide for Alzheimer's disease.
    Asai M; Iwata N; Tomita T; Iwatsubo T; Ishiura S; Saido TC; Maruyama K
    J Neurosci Res; 2010 Dec; 88(16):3588-97. PubMed ID: 20890992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
    Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
    J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statins reduce amyloid-beta production through inhibition of protein isoprenylation.
    Ostrowski SM; Wilkinson BL; Golde TE; Landreth G
    J Biol Chem; 2007 Sep; 282(37):26832-26844. PubMed ID: 17646164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do statins prevent Alzheimer's disease? A narrative review.
    Daneschvar HL; Aronson MD; Smetana GW
    Eur J Intern Med; 2015 Nov; 26(9):666-9. PubMed ID: 26342722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients with Alzheimer's disease may be particularly susceptible to adverse effects of statins.
    Algotsson A; Winblad B
    Dement Geriatr Cogn Disord; 2004; 17(3):109-16. PubMed ID: 14739530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alzheimer's disease: cholesterol, membrane rafts, isoprenoids and statins.
    Reid PC; Urano Y; Kodama T; Hamakubo T
    J Cell Mol Med; 2007; 11(3):383-92. PubMed ID: 17635634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholesterol in Alzheimer's disease.
    Shobab LA; Hsiung GY; Feldman HH
    Lancet Neurol; 2005 Dec; 4(12):841-52. PubMed ID: 16297842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholesterol and Alzheimer's disease.
    Wolozin B
    Biochem Soc Trans; 2002 Aug; 30(4):525-9. PubMed ID: 12196129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Statin for the brain: update in 2008].
    Scheen AJ; Radermecker RP; Sadzot B
    Rev Med Liege; 2008; 63(5-6):287-92. PubMed ID: 18669194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.